Lantern Pharma Inc.
A clinical-stage company using AI and genomics to develop cancer therapies.
LTRN | US
Overview
Corporate Details
- ISIN(s):
- US51654W1018
- LEI:
- Country:
- United States of America
- Address:
- 1920 MCKINNEY AVENUE, 75201 DALLAS
- Website:
- https://www.lanternpharma.com/
- Sector:
- Manufacturing
Description
Lantern Pharma is a clinical-stage pharmaceutical company focused on transforming oncology drug development through the use of artificial intelligence (AI), machine learning, and genomics. The company's data-driven platform is designed to reduce the cost, time, and risk associated with creating new cancer therapies. It works by identifying specific patient biomarkers to predict drug response, enabling the development of precision medicines with novel mechanisms of action. Lantern Pharma's pipeline consists of targeted drug candidates for various cancers, aiming to improve clinical trial success rates and patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lantern Pharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Lantern Pharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lantern Pharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
